Anxiety correlates to decreased blood and prefrontal cortex IGF-1 levels in streptozotocin induced diabetes

Neuroscience Letters

Volumn 531, Issue 2, 2012, Pages 176-181

  Aksu, Ilkay ^a   Ates, Mehmet ^a   Baykara, Basak ^a   Kiray, Muge ^a   Sisman, Ali Riza ^a   Buyuk, Erkan ^b   Baykara, Burak ^a   Cetinkaya, Caner ^a   Gumus, Hikmet ^a   Uysal, Nazan ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Anxiety; Corticosterone; Diabetes; IGF 1; MDA; Prefrontal cortex; SOD

Indexed keywords

CORTICOSTERONE; MALONALDEHYDE; SOMATOMEDIN C; STREPTOZOCIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; APOPTOSIS; ARTICLE; CELL COUNT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; MAZE TEST; NONHUMAN; OPEN FIELD TEST; OXIDATIVE STRESS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; STREPTOZOCIN DIABETES;

ANIMALS; ANXIETY; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; INSULIN-LIKE GROWTH FACTOR I; PREFRONTAL CORTEX; RATS; RATS, WISTAR;

EID: 84870405408     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.10.045     Document Type: Article

References (44)

1. Ajilore O., Narr K., Rosenthal J., Pham D., Hamilton L., Watari K., Elderkin-Thompson V., Darwin C., Toga A., Kumar A. Regional cortical gray matter thickness differences associated with type 2 diabetes and major depression. Psychiatry Research 2010, 184:63-70.
2. Asplin C.M., Faria A.C., Carlsen E.C., Vaccaro V.A., Barr R.E., Iranmanesh A., Lee M.M., Veldhuis J.D., Evans W.S. Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes-mellitus. Journal of Clinical Endocrinology and Metabolism 1989, 69:239-245.
3. Bishop R., Duncan J., Brett M., Lawrence A.D. Prefrontal cortical function and anxiety: controlling attention to threat-related stimuli. Nature Neuroscience 2004, 7:184-188.
4. Chan O., Inouye K., Vranic M., Matthews S.G. Hyperactivation of the hypothalamo-pituitary-adrenocortical axis in streptozotocin-diabetes is associated with reduced stress responsiveness and decreased pituitary and adrenal sensitivity. Endocrinology 2002, 143:1761-1768.
5. Charney D.S., Deutch A.Y., Krystal J.H., Southwick S.M., Davis M. Psychobiologic mechanisms of posttraumatic stress disorder. Archives of General Psychiatry 1993, 50:294-305.
6. Collins M.M., Corcoran P., Perry I.J. Anxiety and depression symptoms in patients with diabetes. Diabetic Medicine 2009, 26:153-161.
7. Csiszar A., Labinskyy N., Perez V., Recchia F.A., Podlutsky A., Mukhopadhyay P., Losonczy G., Pacher P., Austad S.N., Bartke A., Ungvari Z. Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice. American Journal of Physiology. Heart and Circulatory Physiology 2008, 295:H1882-H1894.
8. De Nicola A.F., Fridman O., Del Castillo E.J., Foglia V.G. Abnormal regulation of adrenal function in rats with streptozotocin diabetes. Hormone and Metabolic Research 1977, 9:469-473.
9. Enhamre E., Carlsson A., Grönbladh A., Watanabe H., Hallberg M., Nyberg F. The expression of growth hormone receptor gene transcript in the prefrontal cortex is affected in male mice with diabetes-induced learning impairments. Neuroscience Letters 2012, 523:82-86.
10. Forrest V.J., Kang Y.H., McClain D.E., Robinson D.H., Ramakrishnan N. Oxidative stress-induced apoptosis prevented by Trolox. Free Radical Biology & Medicine 1994, 16:675-684.
11. Gürpi{dotless}nar T., Ekerbiçer N., Uysal N., Barut T., Tarakçi{dotless} F., Tuglu M.I. The effects of the melatonin treatment on the oxidative stress and apoptosis in diabetic eye and brain. Scientific World Journal 2012, 498489. 10.1100/2012/498489.
12. Halliwell B. Reactive oxygen species and the central nervous system. Journal of Neurochemistry 1992, 59:1609-1623.
13. Kern S., Oakes T.R., Stone C.K., McAuliff E.M., Kirschbaum C., Davidson R.J. Glucose metabolic changes in the prefrontal cortex are associated with HPA axis response to a psychosocial stressor. Psychoneuroendocrinology 2008, 33:517-529.
14. Kim M.J., Whalen P.J. The structural integrity of an amygdala-prefrontal pathway predicts trait anxiety. Journal of Neuroscience 2009, 29:11614-11618.
15. Kumar T.P., Antony S., Gireesh G., George N., Paulose C.S. Curcumin modulates dopaminergic receptor, CREB and phospholipase C gene expression in the cerebral cortex and cerebellum of streptozotocin induced diabetic rats. Journal of Biomedical Science 2010, 17:43.
16. Leon J., Acuna-Castroviejo D., Sainz R.M., Mayo J.C., Tan D.X., Reiter R.J. Melatonin and mitochondrial function. Life Sciences 2004, 75:765-790.
17. Llorens-Martín M., Torres-Alemán I., Trejo J.L. Exercise modulates insulin-like growth factor 1-dependent and -independent effects on adult hippocampal neurogenesis and behaviour. Molecular and Cellular Neuroscience 2010, 44:109-117.
18. Maiese K., Chong Z.Z., Shang Y.C. Mechanistic insights into diabetes mellitus and oxidative stress. Current Medicinal Chemistry 2007, 14:1729-1738.
19. Mayhan W.G., Faraci F.M. Responses of cerebral arterioles in diabetic rats to activation of ATP-sensitive potassium channels. American Journal of Physiology 1993, 265:H152-H157.
20. Meehan W.P., Leedom L.J., Nagayama T., Zeidler A. Agonistic behavior patterns in mice with streptozotocin-induced-diabetes mellitus. Physiology and Behavior 1986, 38:301-306.
21. Miyata S., Yamada N., Hirano S., Tanaka S., Kamei J. Diabetes attenuates psychological stress-elicited 5-HT secretion in the prefrontal cortex but not in the amygdala of mice. Brain Research 2007, 1147:233-239.
22. Mitschelen M., Yan H., Farley J.A., Warrington J.P., Han S., Hereñú C.B., Csiszar A., Ungvari Z., Bailey-Downs L.C., Bass C.E., Sonntag W.E. Long-term deficiency of circulating and hippocampal insulin-like growth factor I induces depressive behavior in adult mice: a potential model of geriatric depression. Neuroscience 2011, 185:50-60.
23. Mizoguchi K., Tanaka Y., Tabira T. Anxiolytic effect of a herbal medicine, yokukansan, in aged rats: involvement of serotonergic and dopaminergic transmissions in the prefrontal cortex. Journal of Ethnopharmacology 2010, 127:70-76.
24. 2+ efflux by dopamine in glucose-stimulated pancreatic islets. General Pharmacology 1994, 25:909-916.
25. Olchovsky D., Bruno J.F., Wood T.L., Gelato M.C., Leidy J.W., Gilbert J.M., Berelowitz M. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor. Endocrinology 1990, 126:53-61.
26. Ozdemir D., Baykara B., Aksu I., Kiray M., Sisman A.R., Cetin F., Dayi A., Gurpinar T., Uysal N., Arda M.N. Relationship between circulating IGF-1 levels and traumatic brain injury-induced hippocampal damage and cognitive dysfunction in immature rats. Neuroscience Letters 2012, 507:84-89.
27. Pezze M.A., Feldon J. Mesolimbic dopaminergic pathways in fear conditioning. Progress in Neurobiology 2004, 74:301-320.
28. Plotsky P.M., Thrivikraman K.V., Watts A.G., Hauger R.L. Hypothalamic-pituitary-adrenal axis function in the Zucker obese rat. Endocrinology 1992, 130:1931-1941.
29. Quirk G.J., Beer J.S. Prefrontal involvement in the regulation of emotion: convergence of rat and human studies. Current Opinion in Neurobiology 2006, 16:723-727.
30. Revsin Y., Rekers N.V., Louwe M.C., Saravia F.E., De Nicola A.F., de Kloet E.R., Oitzl M.S. Glucocorticoid receptor blockade normalizes hippocampal alterations and cognitive impairment in streptozotocin-induced type 1 diabetes mice. Neuropsychopharmacology 2009, 34:747-758.
31. Rosen J.B., Schulkin J. From normal fear to pathological anxiety. Psychological Review 1998, 105:325-350.
32. Roy M.S., Roy A., Gallucci W.T., Collier B., Young K., Kamilaris T.C., Chrousos G.P. The ovine corticotropin-releasing hormone-stimulation test in type I diabetic patients and controls: suggestion of mild chronic hypercortisolism. Metabolism 1993, 42:696-700.
33. Rubovitch V., Edut S., Sarfstein R., Werner H., Pick C.G. The intricate involvement of the insulin-like growth factor receptor signaling in mild traumatic brain injury in mice. Neurobiology of Disease 2010, 38:299-303.
34. Scribner K.A., Walker C.D., Cascio C.S., Dallman M.F. Chronic streptozotocin diabetes in rats facilitates the acute stress response without altering pituitary or adrenal responsiveness to secretagogues. Endocrinology 1991, 129:99-108.
35. Serbedzija P., Madl J.E., Ishii D.N. Insulin and IGF-I prevent brain atrophy and DNA loss in diabetes. Brain Research 2009, 1303:179-194.
36. Sharma A.N., Elased K.M., Garrett T.L., Lucot J.B. Neurobehavioral deficits in db/db diabetic mice. Physiology and Behavior 2010, 101:381-388.
37. Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice 2010, 87:4-14.
38. Si W., Aluisio L., Okamura N., Clark S.D., Fraser I., Sutton S.W., Bonaventure P., Reinscheid R.K. Neuropeptide S stimulates dopaminergic neurotransmission in the medial prefrontal cortex. Journal of Neurochemistry 2010, 115:475-482.
39. Simon G.E., VonKorff M., Barlow W. Health care costs of primary care patients with recognized depression. Archives of General Psychiatry 1995, 52:850-856.
40. Torres-Aleman I. Toward a comprehensive neurobiology of IGF-I. Developmental Neurobiology 2010, 70:384-396.
41. Trejo J.L., Piriz J., Llorens-Martin M.V., Fernandez A.M., Bolos M., LeRoith D., Nunez A., Torres-Aleman I. Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects. Molecular Psychiatry 2007, 12:1118-1128.
42. Uysal N., Yalaz G., Acikgoz O., Gonenc S., Kayatekin B.M. Effect of l-carnitine on diabetogenic action of streptozotocin in rats. Neuro Endocrinology Letters 2005, 26:419-422.
43. van Raalte D.H., Nofrate V., Bunck M.C., van Iersel T., Elassaiss Schaap J., Nassander U.K., Heine R.J., Mari A., Dokter W.H., Diamant M. Acute and 2-week exposure to prednisolone impair different aspects of β-cell function in healthy men. European Journal of Endocrinology/European Federation of Endocrine Societies 2010, 162:729-735.
44. Yan H., Mitschelen M., Bixler G.V., Brucklacher R.M., Farley J.A., Han S., Freeman W.M., Sonntag W.E. Circulating IGF-1 regulates hippocampal IGF-1 levels and brain gene expression during adolescence. Journal of Endocrinology 2011, 211:27-37.